Lalistat 2 is a potent and selective lysosomal acid lipase (LAL) inhibitor with an IC50 of 152 nM, showing no activity against related lipases up to 10 µM. This tool compound is valuable for investigating LALs role in lipid metabolism, lysosomal storage disorders, and atherosclerosis in both cellular and animal models.